Prescribing placebos ethically: the appeal of negatively informed consent

Journal of Medical Ethics 35 (2):97-99 (2009)
  Copy   BIBTEX

Abstract

Kihlbom has recently argued that a system of seeking negatively informed consent might be preferable in some cases to the ubiquitous informed consent model. Although this theory is perhaps not powerful enough to supplant informed consent in most settings, it lends strength to Evans’ and Hungin’s proposal that it can be ethical to prescribe placebos rather than "active" drugs. This paper presents an argument for using negatively informed consent for the specific purpose of authorising the use of placebos in clinical contexts.

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 76,400

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Analytics

Added to PP
2009-02-10

Downloads
135 (#94,629)

6 months
2 (#300,644)

Historical graph of downloads
How can I increase my downloads?

Author's Profile

David M. Shaw
University of Basel

Citations of this work

Physician perspectives on placebo ethics.John Bliamptis & Anne Barnhill - 2022 - Journal of Medical Ethics 48 (10):759-763.
Unethical Aspects of Homeopathic Dentistry.David Shaw - 2010 - British Dental Journal 209 (10):493-496.

Add more citations

References found in this work

Principles of Biomedical Ethics.Tom L. Beauchamp - 1979 - New York: Oxford University Press.
The ethics of the placebo in clinical practice.P. Lichtenberg - 2004 - Journal of Medical Ethics 30 (6):551-554.
Autonomy and Negatively Informed Consent.Ulrik Kihlbom - 2008 - Journal of Medical Ethics 34 (3):146-9.

Add more references